comparemela.com

Prior Sales News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NexGen Energy : MATERIAL CHANGE REPORT - Form 6-K

MATERIAL CHANGE REPORT Name and Address of Company NexGen Energy Ltd. Suite 3150, 1021 West Hastings Street .

Hong kongUnited statesSouth koreaNew zealandUnited kingdomBritish columbiaRepublic of koreaLeigh curyerCdis nexgenShelf prospectusInvestments commissionOr territory parliamentNexgen energy ltdEuropean unionProgram to facilitate offeringParliament of australia

NexGen Announces C$180 Million CDI Offering in Australia

/PRNewswire/ - NexGen Energy Ltd. ("NexGen" or the "Company") (TSX: NXE) (NYSE: NXE) (ASX: NXG) is pleased to announce that it has entered into a placement.

British columbiaUnited statesNew yorkUnited kingdomCanaccord genuityCompany base shelf prospectusProgram to facilitate offeringMeagher flomCassels graydonUs base prospectusNexgen energy ltdExchange commissionVirtu americasCompany us base prospectusVirtu canada corpExchange commission on

NexGen Announces Upsized C$224 Million CDI Offering in Australia

, BC, April 30, 2024 - NexGen Energy Ltd. is pleased to announce that it has entered into an amended and restated placement agreement dated April 30, 2024 with a lead manager and bookrunner in Australia, Aitken Mount Capital Partners to upsize its. - Veroeffentlicht am 30.04.2024

British columbiaUnited statesNew yorkUnited kingdomCanaccord genuityMeagher flomNexgen energy ltdVirtu canada corpShelf prospectusExchange commission onProgram to facilitate offeringUs base prospectusExchange commissionCompany base shelf prospectusVirtu americasCompany us base prospectus

NexGen Energy Announces C$180 Million CDI Offering in Australia

Real-Time News, Market Data and Stock Quotes For Junior Mining Stocks.

British columbiaUnited kingdomUnited statesNew yorkCanaccord genuityProgram to facilitate offeringExchange commission onCompany base shelf prospectusNexgen energy ltdShelf prospectusCompany us base prospectusVirtu canada corpVirtu americasUs base prospectusCassels graydonMeagher flom

Lineage Cell Therapeutics : Immediate Report -March 24, 2024 at 04:37 am EDT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT .

New yorkUnited statesCity of new yorkGeorgea samuelSubsidiary of the companyCommission file numberLineage cell therapeutics incExchange commission theGovernmental authorityB riley securities incCantor fitzgerald coCompany the prospectusExchange commissionWarranties of the companyPlacement shares of the companyCompany or lineage

vimarsana © 2020. All Rights Reserved.